AI Science Tracker
EN

Hematology Division, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel

1 discovery from 2023

Discoveries

Image-Based Deep Learning Detection of High-Grade B-Cell Lymphomas Directly from Hematoxylin and Eosin Images

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Self-supervised histology foundation model plus MIL classified DHL/THL from H&E; blinded independent 25-case FISH validation (10 positives) showed 100% sensitivity, 86.7% specificity, AUC .95. Small single-center retrospective proof of concept; broader validation required.

Technology: Self-supervised histology foundation model with multiple-instance learning

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Self-supervised histology foundation model with multiple-instance learning
Limitation / still unknown
The study reports evaluation in the stated cohort, samples, datasets, or engineering setting; performance and practical benefit beyond that evaluated setting remain unknown.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.mdpi.com/2072-6694/15/21/5205 · https://doi.org/10.3390/cancers15215205 · https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=37958379&retmode=xml · https://pubmed.ncbi.nlm.nih.gov/37958379/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.